Global Globin Network and adopting genomic variant database requirements for thalassemia.

Autor: Halim-Fikri H; School of Medical Sciences, Universiti Sains Malaysia, Health Campus, Jalan Raja Perempuan Zainab II, Kubang Kerian, Kelantan 16150, Malaysia., Zulkipli NN; School of Medical Sciences, Universiti Sains Malaysia, Health Campus, Jalan Raja Perempuan Zainab II, Kubang Kerian, Kelantan 16150, Malaysia.; School of Biomedicine, Faculty of Health Sciences, Universiti Sultan Zainal Abidin, Gong Badak Campus, Kuala Nerus, Terengganu 21300, Malaysia., Alauddin H; Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, Cheras, Kuala Lumpur 56000, Malaysia., Bento C; Department of Hematology, Hospital Pediátrico de Coimbra, Avenida Afonso Romão, Coimbra 3000-602, Portugal., Lederer CW; Molecular Genetics Thalassaemia Department, The Cyprus Institute of Neurology & Genetics, 6 Iroon Avenue, Ayios Dometios, Nicosia 2371, Cyprus., Kountouris P; Molecular Genetics Thalassaemia Department, The Cyprus Institute of Neurology & Genetics, 6 Iroon Avenue, Ayios Dometios, Nicosia 2371, Cyprus., Kleanthous M; Molecular Genetics Thalassaemia Department, The Cyprus Institute of Neurology & Genetics, 6 Iroon Avenue, Ayios Dometios, Nicosia 2371, Cyprus., Hernaningsih Y; Department of Clinical Pathology, Faculty of Medicine Universitas Airlangga, Dr. Soetomo Academic General Hospital, Surabaya, East Java 60132, Indonesia., Thong MK; Department of Paediatrics, Faculty of Medicine, Universiti Malaya, Lembah Pantai, Kuala Lumpur 50603, Malaysia., Mahmood MH; Department of Basic Medical Sciences, Faculty of Medicine and Health Sciences, Universiti Malaysia Sarawak, Kota Samarahan, Sarawak 94300, Malaysia., Mohd Yasin N; Haematology Unit, Cancer Research Centre, Institute for Medical Research, National Institutes of Health, No. 1, Jalan Setia Murni U13/52, Seksyen U13, Bandar Setia Alam, Shah Alam, Selangor Darul Ehsan 40170, Malaysia., Esa E; Haematology Unit, Cancer Research Centre, Institute for Medical Research, National Institutes of Health, No. 1, Jalan Setia Murni U13/52, Seksyen U13, Bandar Setia Alam, Shah Alam, Selangor Darul Ehsan 40170, Malaysia., Elion J; Medical School, Université Paris Diderot, Paris 75018, France., Coviello D; Laboratorio di Genetica Umana, IRCCS Istituto Giannina Gaslini, Largo Gerolamo Gaslini 5, Genova 16147, Italy., Raja-Sabudin RZ; Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, Cheras, Kuala Lumpur 56000, Malaysia., El-Kamah G; Clinical Genetics Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo 12622, Egypt., Burn J; Translational and Clinical Research Institute, Newcastle University, International Centre for Life, Times Square, Newcastle upon Tyne NE1 3BZ, United Kingdom., Mohd Yusoff N; Molecular Genetics Section, Clinical Diagnostic Laboratory, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Bertam, Kepala Batas, Pulau Pinang 13200, Malaysia., Ramesar R; Division of Human Genetics, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Observatory 7925, South Africa., Zilfalil BA; Human Genome Centre, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, Jalan Raja Perempuan Zainab II, Kubang Kerian, Kelantan 16150, Malaysia.

Publikováno v: Database : the journal of biological databases and curation [Database (Oxford)] 2024 Sep 04; Vol. 2024.

O-06: E-SICKLE CELL DISEASE: A FRENCH SPEAKING TRAINING PLATFORM TARGETING ALL LEVELS OF THE HEALTHCARE SYSTEM

Autor: COLLIN M., PRZYBYLSKI C., TEYSSIE V., DIAGNE I., ELION J.

Publikováno v: HemaSphere, Vol 6, Pp 04-05 (2022)

Externí odkaz: https://doaj.org/article/aece3bc66fa749fbaec662b3ba486764

Comparative Study of Mycobacterium paratuberculosis Strains Isolated from Crohn's Disease and Johne's Disease Using Restriction Fragment Length Polymorphism and Arbitrarily Primed Polymerase Chain Reaction

Autor: Elion, J.

Publikováno v: Epidemiology and Infection, 1997 Jun 01. 118(3), 227-233.

Externí odkaz: https://www.jstor.org/stable/4617358

Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission.

Autor: Piel FB; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK. Electronic address: f.piel@imperial.ac.uk., Rees DC; Department of Paediatric Haematology, King's College London, King's College Hospital, London, UK., DeBaun MR; Department of Pediatrics, Vanderbilt-Meharry Center of Excellence for Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, TN, USA., Nnodu O; Department of Haematology and Blood Transfusion, College of Health Sciences and Centre of Excellence for Sickle Cell Disease Research and Training, University of Abuja, Abuja, Nigeria., Ranque B; Department of Internal Medicine, Georges Pompidou European Hospital, Assistance Publique-Hopitaux de Paris Centre, University of Paris Cité, Paris, France., Thompson AA; Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Ware RE; Division of Hematology and Global Health Center, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA., Abboud MR; Department of Pediatrics and Adolescent Medicine, and Sickle Cell Program, American University of Beirut, Beirut, Lebanon., Abraham A; Division of Blood and Marrow Transplantation, Children's National Hospital, Washington, DC, USA., Ambrose EE; Department of Paediatrics and Child Health, Bugando Medical Centre, Mwanza, Tanzania., Andemariam B; New England Sickle Cell Institute, University of Connecticut Health, Connecticut, USA., Colah R; Department of Haematogenetics, Indian Council of Medical Research National Institute of Immunohaematology, Mumbai, India., Colombatti R; Pediatric Oncology Hematology Unit, Department of Women's and Children's Health, University of Padua, Padua, Italy., Conran N; Department of Clinical Medicine, School of Medical Sciences, Center of Hematology and Hemotherapy (Hemocentro), University of Campinas-UNICAMP, Campinas, Brazil., Costa FF; Department of Clinical Medicine, School of Medical Sciences, Center of Hematology and Hemotherapy (Hemocentro), University of Campinas-UNICAMP, Campinas, Brazil., Cronin RM; Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., de Montalembert M; Department of Pediatrics, Necker-Enfants Malades Hospital, Assistance Publique-Hopitaux de Paris Centre, Paris, France., Elion J; Paris Cité University and University of the Antilles, Inserm, BIGR, Paris, France., Esrick E; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Greenway AL; Department Clinical Haematology, Royal Children's Hospital, Parkville and Department Haematology, Monash Health, Clayton, VIC, Australia., Idris IM; Department of Hematology, Aminu Kano Teaching Hospital/Bayero University Kano, Kano, Nigeria., Issom DZ; Department of Business Information Systems, School of Management, HES-SO University of Applied Sciences and Arts of Western Switzerland, Geneva, Switzerland., Jain D; Department of Paediatrics, Government Medical College, Nagpur, India., Jordan LC; Department of Pediatrics, Division of Pediatric Neurology, Vanderbilt University Medical Center, Nashville, TN, USA., Kaplan ZS; Department of Clinical Haematology, Monash Health and Monash University, Melbourne, VIC, Australia., King AA; Departments of Pediatrics and Internal Medicine, Divisions of Pediatric Hematology and Oncology and Hematology, Washington University School of Medicine, St Louis, MO, USA., Lloyd-Puryear M; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA., Oppong SA; Department of Obstetrics and Gynecology, University of Ghana Medical School, Accra, Ghana., Sharma A; Department of Bone Marrow Transplantation and Cellular Therapy, St Jude Children's Research Hospital, Memphis, TN, USA., Sung L; Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada., Tshilolo L; Institute of Biomedical Research/CEFA Monkole Hospital Centre and Official University of Mbuji-Mayi, Mbuji-Mayi, Democratic Republic of the Congo., Wilkie DJ; Department of Biobehavioral Nursing Science, College of Nursing, University of Florida, Gainesville, FL, USA., Ohene-Frempong K; Division of Hematology, Children's Hospital of Philadelphia, Pennsylvania, USA; Sickle Cell Foundation of Ghana, Kumasi, Ghana.

Publikováno v: The Lancet. Haematology [Lancet Haematol] 2023 Aug; Vol. 10 (8), pp. e633-e686. Date of Electronic Publication: 2023 Jul 11.

Molecular Analysis of Multiply Recurrent Meningitis Due to Escherichia coli K1 in an Infant

Autor: Bingen, E., Elion, J., Denamur, E.

Publikováno v: Clinical Infectious Diseases, 1993 Jan 01. 16(1), 82-85.

Externí odkaz: https://www.jstor.org/stable/4456854